| Literature DB >> 31554322 |
Sumanto Haldar1, Linda Gan2, Shia Lyn Tay3, Shalini Ponnalagu4, Christiani Jeyakumar Henry5,6.
Abstract
Several plant-based traditional ingredients in Asia are anecdotally used for preventing and/or treating type 2 diabetes. We investigated three such widely consumed ingredients, namely corn silk (CS), cumin (CU), and tamarind (TA). The aim of the study was to determine the effects of aqueous extracts of these ingredients consumed either as a drink (D) with high-glycemic-index rice or added to the same amount of rice during cooking (R) on postprandial glycemia (PPG), insulinemia (PPI), and blood pressure (BP), over a 3 h measurement period. Eighteen healthy Chinese men (aged 37.5 ± 12.5 years, BMI 21.8 ± 1.67 kg/m2) took part in a randomized crossover trial, each completing up to nine sessions. Compared to the control meal (plain rice + plain water), the addition of test extracts in either form did not modulate PPG, PPI, or BP. However, the extracts when added within rice while cooking gave rise to significantly lower PPI than when consumed as a drink (p < 0.01). Therefore, the form of consumption of phytochemical-rich ingredients can differentially modulate glucose homeostasis. This study also highlights the need for undertaking randomized controlled clinical trials with traditional foods/components before claims are made on their specific health effects.Entities:
Keywords: aqueous extracts; corn silk; cumin; form; postprandial glycemia; postprandial insulinemia; tamarind
Year: 2019 PMID: 31554322 PMCID: PMC6835365 DOI: 10.3390/foods8100437
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Food ingredients, energy content, and nutrient composition of the test meals.
| Treatment | Ingredients (per test meal) | Energy or Nutrients (per test meal) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rice (g) | Peas (g) | Dried corn silk (g) | Cumin powder (g) | Tamarind pulp (g) | Energy (kcal) | Carbohydrate (g) | Protein (g) | Fat (g) | Fiber (g) | Available CHO (g) | |
|
| 65 | 20 | - | - | - | 249.70 | 51.56 | 6.65 | 1.60 | 1.77 | 49.79 |
|
| 60 | 20 | 12 | - | - | 248.51 | 51.12 | 6.95 | 1.52 | 2.44 | 48.68 |
|
| 60 | 20 | 24 | - | - | 265.01 | 54.45 | 7.65 | 1.57 | 3.16 | 51.29 |
|
| 60 | 20 | - | 24 | - | 288.16 | 53.53 | 8.29 | 4.26 | 4.11 | 49.42 |
|
| 60 | 20 | - | - | 20 | 259.00 | 52.79 | 6.87 | 1.98 | 2.13 | 50.65 |
CHO: carbohydrates; CON: control; CS12: corn silk 12 g; CS24: corn silk 24 g; CU: cumin; TAM: tamarind.
Figure 1Schematic of study design.
Baseline anthropometric and metabolic characteristics.
| Measurement | Mean ± S.D. |
|---|---|
| Age (Years) | 37.5 ± 12.5 |
| Height (m) | 1.7 ± 0.06 |
| Weight (kg) | 63.9 ± 7.09 |
| Body mass index (kg/m2) | 21.8 ± 1.67 |
| Body fat (%) | 16.5 ± 4.25 |
| Waist (cm) | 78.8 ± 5.36 |
| Systolic blood pressure (mmHg) | 120.0 ± 7.75 |
| Diastolic blood pressure (mmHg) | 76.5 ± 7.37 |
| Resting heart rate (bpm) | 64. ± 10.03 |
| Fasting blood glucose (mmol/L) | 5.2 ± 0.43 |
Figure 2Postprandial changes in plasma glucose concentration during various treatments. CSD12: corn silk drink 12 g; CSR12: corn silk rice 12 g; CSD24: corn silk drink 24 g; CSR24: corn silk rice 24 g; CUD: cumin drink; CUR: cumin rice; TAMD: tamarind drink; TAMR: tamarind rice.
Figure 3Postprandial changes in plasma insulin concentration during various treatments. CSD12: corn silk drink 12 g; CSR12: corn silk rice 12 g; CSD24: corn silk drink 24 g; CSR24: corn silk rice 24 g; CUD: cumin drink; CUR: cumin rice; TAMD: tamarind drink; TAMR: tamarind rice.
Incremental areas under the curve (iAUCs) for postprandial glucose and insulin over relevant time periods during various treatments.
| Test Meal | iAUC 0–30 min | iAUC 0–120 min | iAUC 0–180 min | |||
|---|---|---|---|---|---|---|
| Glucose (mmol min/L) | Insulin (µU min/mL) | Glucose (mmol min/L) | Insulin (µU min/mL) | Glucose (mmol min/L) | Insulin (µU min/mL) | |
| 36.55 ± 5.08 | 908.43 ± 141.98 | 158.06 ± 29.17 | 5598.56 ± 708.59 | 159.91 ± 29.59 | 6008.20 ± 751.33 | |
|
| ||||||
| Corn silk (12 g) | 36.15 ± 6.77 | 836.69 ± 128.20 | 147.99 ± 28.12 | 4802.84 ± 583.04 | 148.16 ± 28.11 | 5028.97 ± 633.59 |
| Corn silk (24 g) | 37.71 ± 4.18 | 839.87 ± 113.04 | 165.37 ± 30.87 | 4570.14 ± 543.70 | 171.41 ± 33.18 | 4890.21 ± 598.19 |
| Cumin | 44.12 ± 7.04 | 915.75 ± 106.42 | 193.05 ± 30.72 | 5223.44 ± 720.45 | 205.80 ± 33.69 | 5627.36 ± 817.57 |
| Tamarind | 38.97 ± 5.54 | 764.41 ± 110.33 | 181.02 ± 28.10 | 4503.82 ± 558.78 | 183.04 ± 28.37 | 4773.23 ± 591.69 |
|
| ||||||
| Corn silk (12 g) | 40.98 ± 6.37 | 768.77 ± 101.19 | 220.90 ± 41.98 | 5138.30 ± 681.74 | 230.45 ± 45.09 | 5591.53 ± 723.78 |
| Corn silk (24 g) | 39.30 ± 5.37 | 944 ± 148.22 | 183.03 ± 29.20 | 5386.49 ± 698.89 | 186.99 ± 30.32 | 5729.12 ± 724.89 |
| Cumin | 38.54 ± 5.32 | 893.25 ± 96.40 | 167.52 ± 29.34 | 5768.09 ± 676.85 | 169.21 ± 29.96 | 6085.28 ± 714.54 |
| Tamarind | 39.32 ± 5.39 | 829.59 ± 98.12 | 182.05 ± 28.01 | 5679.60 ± 773.40 | 186.40 ± 29.89 | 6047.60 ± 814.98 |
|
| 0.912 | 0.499 | 0.404 | 0.080 | 0.310 | 0.051 |
|
| 0.632 | 0.601 | 0.143 | 0.669 | 0.091 | 0.721 |
|
| 0.973 | 0.647 | 0.274 | 0.005 | 0.329 | 0.003 |
|
| 0.932 | 0.176 | 0.983 | 0.247 | 0.985 | 0.227 |
a All analyses were done using the linear mixed effects procedure with compound symmetry covariance structure in SPSS. b Model testing effects of treatment overall, including control. c Model testing effects of form × treatment without control. Bold lettering indicates p < 0.05.
Figure 4Postprandial changes in systolic blood pressure during various treatments. corn silk drink 12 g; CSR12: corn silk rice 12 g; CSD24: corn silk drink 24 g; CSR24: corn silk rice 24 g; CUD: cumin drink; CUR: cumin rice; TAMD: tamarind drink; TAMR: tamarind rice.
Figure 5Postprandial changes in diastolic blood pressure during various treatments. CSD12: corn silk drink 12 g; CSR12: corn silk rice 12 g; CSD24: corn silk drink 24 g; CSR24: corn silk rice 24 g; CUD: cumin drink; CUR: cumin rice; TAMD: tamarind drink; TAMR: tamarind rice.
Baseline and total areas under the curve (tAUCs) of blood pressure over the postprandial period.
| Treatment | Baseline (0 min) | Total AUC 0–180 min | ||
|---|---|---|---|---|
| Systolic BP (mmHg) | Diastolic BP (mmHg) | Systolic BP (mmHg min) | Diastolic BP (mmHg min) | |
|
| 114.58 ± 3.12 | 71.56 ± 2.52 | 20,815.00 ± 528.18 | 12,902.50 ± 391.60 |
|
| ||||
|
| 115.19 ± 2.25 | 72.81 ± 2.59 | 20,493.75 ± 458.67 | 11,454.17 ± 1049.87 |
|
| 112.91 ± 3.16 | 72.91 ± 2.32 | 20,270.63 ± 526.11 | 11,385.83 ± 1034.56 |
|
| 113.61 ± 2.37 | 73.22 ± 2.65 | 20,689.17 ± 471.23 | 12,929.17 ± 419.73 |
|
| 110.59 ± 3.11 | 70.0 ± 2.68 | 20,331.18 ± 487.74 | 12,169.17 ± 842.99 |
|
| ||||
|
| 112.22 ± 2.57 | 72.0 ± 2.48 | 20,349.38 ± 448.14 | 11,344.17 ± 1030.44 |
|
| 115.25 ± 2.46 | 73.41 ± 2.07 | 20,701.88 ± 511.97 | 11,649.17 ± 1046.57 |
|
| 113.69 ± 2.74 | 72.61 ± 2.17 | 20,769.17 ± 448.02 | 13,054.17 ± 381.35 |
|
| 115.88 ± 2.44 | 72.06 ± 1.84 | 20,777.65 ± 365.70 | 12,315.83 ± 801.08 |
|
| 0.206 | 0.705 | 0.624 | 0.393 |